Ventyx Biosciences, Inc. (VTYX)
VTYX Stock Price Chart
Explore Ventyx Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze VTYX price movements and trends.
VTYX Company Profile
Discover essential business fundamentals and corporate details for Ventyx Biosciences, Inc. (VTYX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
21 Oct 2021
Employees
81.00
Website
https://www.ventyxbio.comCEO
Raju S. Mohan
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that is in phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of systemic inflammatory diseases, such as cardiovascular, hepatic, renal, and rheumatologic diseases which is in phase I clinical trials. In addition, the company develops CNS-penetrant NLRP3 inhibitors for the treatment of Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, and multiple sclerosis. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.
VTYX Financial Timeline
Browse a chronological timeline of Ventyx Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.44.
Earnings released on 7 Aug 2025
EPS came in at -$0.38 surpassing the estimated -$0.45 by +15.56%.
Earnings released on 8 May 2025
EPS came in at -$0.39 surpassing the estimated -$0.48 by +18.75%.
Earnings released on 27 Feb 2025
EPS came in at -$0.41 surpassing the estimated -$0.54 by +24.07%.
Earnings released on 7 Nov 2024
EPS came in at -$0.50 falling short of the estimated -$0.48 by -4.17%.
Earnings released on 8 Aug 2024
EPS came in at -$0.45 surpassing the estimated -$0.57 by +21.05%.
Earnings released on 9 May 2024
EPS came in at -$0.62 surpassing the estimated -$0.67 by +7.46%.
Earnings released on 27 Feb 2024
EPS came in at -$0.79 falling short of the estimated -$0.78 by -1.28%, while revenue for the quarter reached $1.08M .
Earnings released on 9 Nov 2023
EPS came in at -$0.92 falling short of the estimated -$0.85 by -8.24%.
Earnings released on 10 Aug 2023
EPS came in at -$0.91 falling short of the estimated -$0.71 by -28.17%.
Earnings released on 11 May 2023
EPS came in at -$0.68 falling short of the estimated -$0.64 by -6.25%.
Earnings released on 23 Mar 2023
EPS came in at -$0.62 falling short of the estimated -$0.59 by -5.08%.
Earnings released on 3 Nov 2022
EPS came in at -$0.59 falling short of the estimated -$0.45 by -31.11%.
Earnings released on 15 Aug 2022
EPS came in at -$0.39 surpassing the estimated -$0.47 by +17.02%.
Earnings released on 12 May 2022
EPS came in at -$0.45 falling short of the estimated -$0.37 by -21.62%.
Earnings released on 23 Mar 2022
EPS came in at -$0.36 surpassing the estimated -$1.00 by +64.00%.
Earnings released on 17 Nov 2021
EPS came in at -$3.17 falling short of the estimated -$0.36 by -780.56%.
Earnings released on 21 Oct 2021
EPS came in at -$0.74 .
Earnings released on 31 Mar 2021
EPS came in at -$1.78 .
Earnings released on 31 Dec 2020
EPS came in at -$0.79 .
Earnings released on 30 Sept 2020
EPS came in at -$0.34 .
VTYX Stock Performance
Access detailed VTYX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.